PROCEPT BioRobotics Corporation PRCT
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -38.97%
- 1 year
- -44.15%
- Open
- 20.33
- Prev close
- 20.30
- Mkt cap
- 1.10B
- Vol
- 856.46K
- Avg vol
- 1.35M
- EPS
- -1.94
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 18.90
- High
- 20.37
- Forward P/E
- -16.38
- Beta
- 0.92
- Short ratio
- 5.27
- Inst. own
- 97.75%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 19.43
- 200-d avg
- 23.38
- 1y target
- 22.25
5D chart
Signals (113)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 3:40 PM | 1 day ago |
| SMA: Bullish | Oct 30, 3:30 PM | 1 day ago |
| MACD: Buy Signal | Oct 30, 3:25 PM | 1 day ago |
| MACD: Sell Signal | Oct 30, 3:05 PM | 1 day ago |
| RSI: Oversold | Oct 30, 3:05 PM | 1 day ago |
| SMA: Bearish | Oct 30, 2:00 PM | 1 day ago |
| SMA: Bullish | Oct 30, 1:50 PM | 1 day ago |
| MACD: Buy Signal | Oct 30, 1:50 PM | 1 day ago |
| RSI: Oversold | Oct 30, 1:30 PM | 1 day ago |
| MACD: Sell Signal | Oct 30, 1:10 PM | 1 day ago |
| RSI: Oversold | Oct 30, 1:10 PM | 1 day ago |
| SMA: Bearish | Oct 30, 12:45 PM | 1 day ago |
| SMA: Bearish | Oct 30, 12:35 PM | 1 day ago |
| SMA: Bullish | Oct 30, 12:15 PM | 1 day ago |
| SMA: Bearish | Oct 30, 11:20 AM | 1 day ago |
| SMA: Bullish | Oct 30, 11:10 AM | 1 day ago |
| MACD: Buy Signal | Oct 30, 11:10 AM | 1 day ago |
| RSI: Oversold | Oct 30, 10:10 AM | 1 day ago |
| RSI: Oversold | Oct 30, 9:45 AM | 1 day ago |
| SMA: Bearish | Oct 30, 9:30 AM | 1 day ago |
| SMA: Bearish | Oct 30, 9:30 AM | 1 day ago |
| MACD: Sell Signal | Oct 30, 9:30 AM | 1 day ago |
| MACD: Buy Signal | Oct 29, 3:55 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:50 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:50 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:40 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 3:40 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:25 PM | 2 days ago |
| SMA: Bullish | Oct 29, 2:50 PM | 2 days ago |
| SMA: Bearish | Oct 29, 2:45 PM | 2 days ago |
| SMA: Bullish | Oct 29, 2:10 PM | 2 days ago |
| SMA: Bullish | Oct 29, 2:00 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 2:00 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 1:35 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 1:25 PM | 2 days ago |
| SMA: Bullish | Oct 29, 12:50 PM | 2 days ago |
| SMA: Bearish | Oct 29, 12:45 PM | 2 days ago |
| SMA: Bullish | Oct 29, 12:40 PM | 2 days ago |
| SMA: Bearish | Oct 29, 11:25 AM | 2 days ago |
| SMA: Bearish | Oct 29, 11:25 AM | 2 days ago |
| SMA: Bullish | Oct 29, 11:05 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 10:25 AM | 2 days ago |
| RSI: Overbought | Oct 29, 9:40 AM | 2 days ago |
| SMA: Bullish | Oct 29, 9:35 AM | 2 days ago |
| SMA: Bullish | Oct 29, 9:35 AM | 2 days ago |
| MACD: Buy Signal | Oct 29, 9:35 AM | 2 days ago |
| SMA: Bearish | Oct 29, 9:30 AM | 2 days ago |
| SMA: Bearish | Oct 29, 9:30 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 9:30 AM | 2 days ago |
| SMA: Bullish | Oct 28, 3:55 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:50 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:35 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 3:10 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:05 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:00 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:50 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:55 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:50 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:45 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 1:35 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:20 PM | 3 days ago |
| SMA: Bearish | Oct 28, 12:35 PM | 3 days ago |
| SMA: Bullish | Oct 28, 12:10 PM | 3 days ago |
| SMA: Bearish | Oct 28, 12:00 PM | 3 days ago |
| SMA: Bullish | Oct 28, 11:55 AM | 3 days ago |
| SMA: Bearish | Oct 28, 11:50 AM | 3 days ago |
| SMA: Bearish | Oct 28, 11:25 AM | 3 days ago |
| MACD: Sell Signal | Oct 28, 11:25 AM | 3 days ago |
| SMA: Bullish | Oct 28, 11:10 AM | 3 days ago |
| SMA: Bearish | Oct 28, 11:05 AM | 3 days ago |
| SMA: Bullish | Oct 28, 10:50 AM | 3 days ago |
| SMA: Bearish | Oct 28, 10:45 AM | 3 days ago |
| SMA: Bullish | Oct 28, 9:50 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 9:50 AM | 3 days ago |
| RSI: Overbought | Oct 28, 9:50 AM | 3 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 3 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 3 days ago |
| SMA: Bullish | Oct 27, 3:50 PM | 4 days ago |
| SMA: Bullish | Oct 27, 3:50 PM | 4 days ago |
| SMA: Bearish | Oct 27, 3:45 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 3:10 PM | 4 days ago |
| SMA: Bearish | Oct 27, 3:00 PM | 4 days ago |
| RSI: Overbought | Oct 27, 2:35 PM | 4 days ago |
| RSI: Overbought | Oct 27, 2:05 PM | 4 days ago |
| SMA: Bullish | Oct 27, 12:55 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 12:45 PM | 4 days ago |
| SMA: Bullish | Oct 27, 12:05 PM | 4 days ago |
| SMA: Bearish | Oct 27, 11:10 AM | 4 days ago |
| MACD: Sell Signal | Oct 27, 11:10 AM | 4 days ago |
| MACD: Buy Signal | Oct 27, 10:50 AM | 4 days ago |
| SMA: Bullish | Oct 27, 10:45 AM | 4 days ago |
| SMA: Bearish | Oct 27, 10:40 AM | 4 days ago |
| SMA: Bullish | Oct 27, 10:35 AM | 4 days ago |
| SMA: Bullish | Oct 27, 10:35 AM | 4 days ago |
| SMA: Bearish | Oct 27, 10:15 AM | 4 days ago |
| SMA: Bullish | Oct 27, 10:05 AM | 4 days ago |
| SMA: Bearish | Oct 27, 10:00 AM | 4 days ago |
| SMA: Bearish | Oct 27, 9:55 AM | 4 days ago |
| MACD: Sell Signal | Oct 27, 9:55 AM | 4 days ago |
| SMA: Bullish | Oct 27, 9:50 AM | 4 days ago |
| SMA: Bearish | Oct 27, 9:45 AM | 4 days ago |
| SMA: Bullish | Oct 27, 9:40 AM | 4 days ago |
| SMA: Bearish | Oct 27, 9:35 AM | 4 days ago |
| RSI: Overbought | Oct 26, 3:50 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:35 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:00 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:50 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:25 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:20 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 1:20 PM | 5 days ago |
| RSI: Oversold | Oct 26, 1:05 PM | 5 days ago |
| SMA: Bearish | Oct 26, 11:45 AM | 5 days ago |
| SMA: Bearish | Oct 26, 10:30 AM | 5 days ago |
News
3 days ago zacks.com
PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
PROCEPT BIOROBO (PRCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 days ago globenewswire.com
Important Notice to Long-Term Shareholders of Beta Bionics, Inc. (NASDAQ: BBNX); GoDaddy Inc. (NYSE: GDDY); Hub Group, Inc. (NASDAQ: HUBG); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Office is Investigating Claims on Your Behalf
PHILADELPHIA, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ: BBNX): Grabar Law Office is investigating claims on behalf of shareholders of Beta Bionics, Inc. (NASDAQ: BBNX). What is…
1 week ago seekingalpha.com
PROCEPT BioRobotics: Compelling Bet On Aquablation's Growth
PROCEPT BioRobotics offers Aquablation to help with symptom relief while preserving sexual and urinary functions for patients. PRCT has ongoing HYDROS placements that further expand its commercial…
1 week ago gurufocus.com
PROCEPT BioRobotics Corp (PRCT) Shares Surge 4.0% -- What GF Score of 71 Tells Investors
On October 19, 2026, PROCEPT BioRobotics Corp (PRCT) shares rose 4.0% to a current price of $18.28. This price is within a 52-week range of $16.67 to $38.11, re
2 weeks ago globenewswire.com
PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026
SAN JOSE, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing…
-
3 weeks ago benzinga.com
Barclays Initiates Coverage On PROCEPT BioRobotics with Overweight Rating, Announces Price Target of $30
Barclays analyst Christopher Pasquale initiates coverage on PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight rating and announces Price Target of $30.
1 month ago prnewswire.com
PROCEPT BioRobotics (NASDAQ: PRCT) Investors: Securities Class Action Filed; Shareholders Should Contact Shareholders Foundation
SAN DIEGO, Oct. 1, 2026 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit has been filed concerning certain investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT).…
1 month ago globenewswire.com
LAWSUIT ALERT: Investors who lost money with PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares should contact the Shareholders Foundation
A lawsuit was filed for certain investors in PROCEPT BioRobotics Corporation shares. NASDAQ: PRCT investors should contact the Shareholders Foundation
1 month ago defenseworld.net
PROCEPT BioRobotics (NASDAQ:PRCT) & Varex Imaging (NASDAQ:VREX) Critical Analysis
Varex Imaging (NASDAQ: VREX - Get Free Report) and PROCEPT BioRobotics (NASDAQ: PRCT - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare…
1 month ago globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PROCEPT BioRobotics Corporation of Class Action Lawsuit and Upcoming Deadlines – PRCT
NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation (“Procept” or the “Company”) (NASDAQ: PRCT).…
1 month ago newsfilecorp.com
Kaplan Fox Encourages PROCEPT BioRobotics Corporation (PRCT) Investors to Take Immediate Action in the Securities Class Action Before September 22, 2026
New York, New York--(Newsfile Corp. - September 22, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation ("PROCEPT" or the…
1 month ago globenewswire.com
Portnoy Law Firm Announces Class Action on Behalf of PROCEPT BioRobotics Corporation Investors
LOS ANGELES, Sept. 22, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises PROCEPT BioRobotics Corporation, (“PROCEPT” or the "Company") (NASDAQ: PRCT) investors of a class action on behalf of…
1 month ago prnewswire.com
PROCEPT BioRobotics Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PRCT
NEW YORK, Sept. 22, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against PROCEPT BioRobotics Corporation ("Procept" or "the Company") (NASDAQ: PRCT ) violations…
1 month ago newsfilecorp.com
Kaplan Fox Alerts PROCEPT BioRobotics Corporation (PRCT) Investors With Losses to a Securities Class Action - Act Before the September 22, 2026 Deadline
New York, New York--(Newsfile Corp. - September 21, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation ("PROCEPT" or the…
1 month ago prnewswire.com
PRCT Deadline: PRCT Investors with Losses in Excess of $100K Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit
NEW YORK, Sept. 21, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February…
1 month ago globenewswire.com
Deadline Alert: PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
LOS ANGELES, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming September 22, 2026 deadline to file a lead plaintiff motion in the class action…
1 month ago businesswire.com
PRCT Deadline: Rosen Law Firm Urges PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of common stock of PROCEPT BioRobotics…
1 month ago prnewswire.com
PRCT FINAL DEADLINE ALERT: PROCEPT BioRobotics Corporation Investors Alerted to September 22, 2026 Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit
SAN FRANCISCO, Sept. 21, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) that a securities class action has been filed after…
1 month ago globenewswire.com
Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Seeking Recovery to Contact the Firm Before September 22, 2026
NEW YORK, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation (“PROCEPT” or the “Company”)…
1 month ago globenewswire.com
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit with SBS Law
LOS ANGELES, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against PROCEPT…
1 month ago globenewswire.com
Long-Term Shareholders of PROCEPT BioRobotics Corporation (PRCT) Are Encouraged to Contact Johnson Fistel Regarding Potential Claims
SAN DIEGO, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of current, long-term shareholders of PROCEPT BioRobotics Corporation (NASDAQ: PRCT)…
-
2 months ago benzinga.com
TD Cowen Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $28
TD Cowen analyst Joshua Jennings maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and lowers the price target from $34 to $28.
-
2 months ago benzinga.com
Piper Sandler Maintains Overweight on PROCEPT BioRobotics, Lowers Price Target to $25
Piper Sandler analyst Matt O'Brien maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and lowers the price target from $35 to $25.
-
2 months ago benzinga.com
Evercore ISI Group Maintains Outperform on PROCEPT BioRobotics, Lowers Price Target to $23
Evercore ISI Group analyst Vijay Kumar maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Outperform and lowers the price target from $30 to $23.
-
2 months ago benzinga.com
William Blair Downgrades PROCEPT BioRobotics to Market Perform
William Blair analyst Brandon Vazquez downgrades PROCEPT BioRobotics (NASDAQ:PRCT) from Outperform to Market Perform.
-
2 months ago benzinga.com
PROCEPT BioRobotics Affirms FY2026 Sales Guidance of $390.000M-$410.000M vs $397.424M Est
PROCEPT BioRobotics (NASDAQ:PRCT) affirms FY2026 sales outlook from $390.000 million-$410.000 million to $390.000 million-$410.000 million vs $397.424 million estimate.
-
2 months ago benzinga.com
PROCEPT BioRobotics Q2 EPS $(0.47) Misses $(0.46) Estimate, Sales $94.498M Beat $92.893M Estimate
PROCEPT BioRobotics (NASDAQ:PRCT) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.46) by 2.17 percent. This is a 34.29 percent decrease over losses…
-
3 months ago benzinga.com
Truist Securities Downgrades PROCEPT BioRobotics to Hold, Lowers Price Target to $25
Truist Securities analyst Richard Newitter downgrades PROCEPT BioRobotics (NASDAQ:PRCT) from Buy to Hold and lowers the price target from $30 to $25.
4 months ago benzinga.com
This Nucor Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
Wall Street analysts upgraded various top stocks, including Nucor, Varonis, Invitation Homes, and Macerich. See what experts say about NUE.
4 months ago benzinga.com
This Take-Two Interactive Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Wall Street analysts changed outlook on top names, see all changes on Benzinga's analyst ratings page. Check out views on BB, SLGL, PRCT, OGE, TTWO.
-
4 months ago benzinga.com
Evercore ISI Group Initiates Coverage On PROCEPT BioRobotics with Outperform Rating, Announces Price Target of $30
Evercore ISI Group analyst Vijay Kumar initiates coverage on PROCEPT BioRobotics (NASDAQ:PRCT) with a Outperform rating and announces Price Target of $30.
4 months ago benzinga.com
Top 3 Health Care Stocks You'll Regret Missing In Q2
Health care sector's oversold stocks present buying opportunity; RSI below 30 signals oversold, according to Benzinga Pro. iRhythm, Procept Biorobotics, Anbio Biotechnology among lowest RSI values.
4 months ago benzinga.com
This MarketAxess Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday
Wall Street analysts changed outlook on top names like MKTX, PRCT, VOD, and JILL. See ratings page and analysts' views before buying MKTX stock.
-
4 months ago benzinga.com
Leerink Partners Downgrades PROCEPT BioRobotics to Market Perform, Lowers Price Target to $29
Leerink Partners analyst Mike Kratky downgrades PROCEPT BioRobotics (NASDAQ:PRCT) from Outperform to Market Perform and lowers the price target from $31 to $29.
-
5 months ago benzinga.com
PROCEPT BioRobotics Announces Two Milestones In Its WATER IV Prostate Cancer Clinical Program
PROCEPT BioRobotics (NASDAQ:PRCT) today announced two milestones in its WATER IV prostate cancer clinical program: completion of enrollment in the randomized WATER IV study evaluating Aquablation®…
-
6 months ago benzinga.com
Piper Sandler Reiterates Overweight on PROCEPT BioRobotics, Raises Price Target to $35
Piper Sandler analyst Matt O'Brien reiterates PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and raises the price target from $28 to $35.
6 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
-
6 months ago benzinga.com
PROCEPT BioRobotics Affirms FY2026 Sales Guidance of $390.000M-$410.000M vs $396.674M Est
PROCEPT BioRobotics (NASDAQ:PRCT) affirms FY2026 sales outlook from $390.000 million-$410.000 million to $390.000 million-$410.000 million vs $396.674 million estimate.
-
6 months ago benzinga.com
PROCEPT BioRobotics Q1 EPS $(0.56), Inline, Sales $83.132M Beat $80.506M Estimate
PROCEPT BioRobotics (NASDAQ:PRCT) reported quarterly losses of $(0.56) per share which met the analyst consensus estimate. This is a 24.44 percent decrease over losses of $(0.45) per share from the…
6 months ago benzinga.com
Earnings Scheduled For April 29, 2026
Earnings Scheduled For April 29, 2026
-
7 months ago benzinga.com
Baird Initiates Coverage On PROCEPT BioRobotics with Neutral Rating, Announces Price Target of $30
Baird analyst David Rescott initiates coverage on PROCEPT BioRobotics (NASDAQ:PRCT) with a Neutral rating and announces Price Target of $30.
8 months ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
-
8 months ago benzinga.com
Truist Securities Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $30
Truist Securities analyst Richard Newitter maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and lowers the price target from $47 to $30.
-
8 months ago benzinga.com
Leerink Partners Maintains Outperform on PROCEPT BioRobotics, Lowers Price Target to $30
Leerink Partners analyst Mike Kratky maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Outperform and lowers the price target from $55 to $30.
-
8 months ago benzinga.com
TD Cowen Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $34
TD Cowen analyst Joshua Jennings maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and lowers the price target from $50 to $34.
8 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
-
8 months ago benzinga.com
Piper Sandler Maintains Overweight on PROCEPT BioRobotics, Lowers Price Target to $28
Piper Sandler analyst Matt O'Brien maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and lowers the price target from $50 to $28.
-
8 months ago benzinga.com
Wells Fargo Maintains Overweight on PROCEPT BioRobotics, Lowers Price Target to $34
Wells Fargo analyst Nathan Treybeck maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and lowers the price target from $51 to $34.
8 months ago benzinga.com
C3.ai Posts Downbeat Results, Joins Trade Desk, FTAI Aviation And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
C3.ai Posts Downbeat Results, Joins Trade Desk, FTAI Aviation And Other Big Stocks Moving Lower In Thursday's Pre-Market Session